A PHASE II, MULTICENTER, RANDOMIZED, DOUBLE MASKED, ACTIVE COMPARATOR-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY, SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF RO7200220 IN COMBINATION WITH RANIBIZUMB ADMINISTERED INTRAVITREALLY I
Research Grant
Administered By
Ophthalmology
Awarded By
Roche TCRC, Inc
Start Date
October 4, 2021
End Date
November 30, 2024
Administered By
Ophthalmology
Awarded By
Roche TCRC, Inc
Start Date
October 4, 2021
End Date
November 30, 2024